(Philadelphia, PA) - Three faculty members of
the University of Pennsylvania School of Medicine
were named Fellows of the American Association for the Advancement
of Science (AAAS) last week. Three other Penn faculty were also
elected, bringing the total to six Penn professors in this year’s
list of 376 new members.
AAAS recognizes members for their scientifically or socially distinguished
efforts to advance science or its applications. The new Fellows
will be officially inducted February 18 during the 2006 AAAS Annual
Meeting in St. Louis.
This year’s AAAS Fellows were announced in the AAAS News &
Notes section of the journal Science on Oct. 28.
The new Penn AAAS Fellows are:
 |
Ian A. Blair, professor of pharmacology,
School of Medicine
Citation: For distinguished contributions to the field
of mass spectrometry and its applications to pharmaceutical
medicine and for moving autocoid biology forward with sensitive
bioanalytical techniques. |
 |
Richard L. Doty, professor of otorhinolaryngology,
School of Medicine, and director of Penn's
Smell and Taste Center
Citation: For distinguished contributions to the field
of sensory measurement and for the development of the first
widely used standardized test of olfactory function. |
 |
Irwin B. Levitan, professor and chair of
neuroscience in Penn's School of Medicine
Citation: For pioneering studies of the regulation
of neuronal electrical activity with focus on the modulation
of ion channels in the neuronal plasma membrane. |
 |
Dawn A. Bonnell, professor of material sciences
and engineering, School of Engineering and Applied Sciences,
and director of Penn's Nano/Bio Interface Center
Citation: For seminal studies in interface mediated
behavior in nanostructures, as well as for leadership in the
U.S. nanoscience community. |
 |
Howard Kunreuther, professor of decision
sciences and business and public policy, Wharton School,
and co-director of Penn's Risk Management and Decision Processes
Center
Citation: For distinguished contributions to the understanding
of environmental and technological risks and for developing
tools for risk assessment and management. |
 |
Michael J. Therien, professor of chemistry,
School of Arts and Sciences
Citation: For seminal contributions to the design,
synthesis and physical characterization of novel chemical structures
with key application in electron transfer, photonics, and medical
imaging. |
###
PENN Medicine is a $2.7 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn’s School of Medicine is ranked #2 in the nation
for receipt of NIH research funds; and ranked #4 in the nation in
U.S. News & World Report’s most recent ranking of top
research-oriented medical schools. Supporting 1,400 fulltime faculty
and 700 students, the School of Medicine is recognized worldwide
for its superior education and training of the next generation of
physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System comprises: its
flagship hospital, the Hospital of the University of Pennsylvania,
consistently rated one of the nation’s “Honor Roll”
hospitals by U.S. News & World Report; Pennsylvania Hospital,
the nation's first hospital; Penn Presbyterian Medical Center; a
faculty practice plan; a primary-care provider network; two multispecialty
satellite facilities; and home health care and hospice.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.